Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Cyclin-dependent kinase 4 inhibitor B (Multiple tumor suppressor 2) (MTS-2) (p14-INK4b) (p15-INK4b) (p15INK4B)

 CDN2B_HUMAN             Reviewed;         138 AA.
P42772; O15125; Q6FI09;
01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
01-NOV-1995, sequence version 1.
18-JUL-2018, entry version 166.
RecName: Full=Cyclin-dependent kinase 4 inhibitor B;
AltName: Full=Multiple tumor suppressor 2;
Short=MTS-2;
AltName: Full=p14-INK4b;
AltName: Full=p15-INK4b;
Short=p15INK4B;
Name=CDKN2B; Synonyms=MTS2;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
PubMed=8001816; DOI=10.1101/gad.8.24.2939;
Guan K.-L., Jenkins C.W., Li Y., Nichols M.A., Wu X., O'Keefe C.L.,
Matera G.A., Xiong Y.;
"Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related
CDK6 inhibitor, correlates with wild-type pRb function.";
Genes Dev. 8:2939-2952(1994).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
PubMed=8078588; DOI=10.1038/371257a0;
Hannon G.J., Beach D.;
"p15INK4B is a potential effector of TGF-beta-induced cell cycle
arrest.";
Nature 371:257-261(1994).
[3]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), SUBCELLULAR LOCATION, AND
TISSUE SPECIFICITY.
PubMed=9230210;
Tsubari M., Tiihonen E., Laiho M.;
"Cloning and characterization of p10, an alternatively spliced form of
p15 cyclin-dependent kinase inhibitor.";
Cancer Res. 57:2966-2973(1997).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
Korn B., Zuo D., Hu Y., LaBaer J.;
"Cloning of human full open reading frames in Gateway(TM) system entry
vector (pDONR201).";
Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
[5]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
NIEHS SNPs program;
Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=15164053; DOI=10.1038/nature02465;
Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
Rogers J., Dunham I.;
"DNA sequence and analysis of human chromosome 9.";
Nature 429:369-374(2004).
[7]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
TISSUE=Skin;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[8]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 53-138.
PubMed=8153634; DOI=10.1126/science.8153634;
Kamb A., Gruis N.A., Weaver-Feldhaus J., Liu Q., Harshman K.,
Tavtigian S.V., Stockert E., Day R.S. III, Johnson B.E.,
Skolnick M.H.;
"A cell cycle regulator potentially involved in genesis of many tumor
types.";
Science 264:436-440(1994).
[9]
STRUCTURE BY NMR.
PubMed=10892805; DOI=10.1110/ps.9.6.1120;
Yuan C., Selby T.L., Li J., Byeon I.J., Tsai M.D.;
"Tumor suppressor INK4: refinement of p16INK4A structure and
determination of p15INK4B structure by comparative modeling and NMR
data.";
Protein Sci. 9:1120-1128(2000).
[10]
VARIANTS LUNG ADENOCARCINOMA GLU-47 AND VAL-50.
PubMed=7882351;
Okamoto A., Hussain S.P., Hagiwara K., Spillare E.A., Rusin M.R.,
Demetrick D.J., Serrano M., Hannon G.J., Shiseki M., Zariwala M.,
Xiong Y., Beach D.H., Yokota J., Harris C.C.;
"Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in
primary and metastatic lung cancer.";
Cancer Res. 55:1448-1451(1995).
-!- FUNCTION: Interacts strongly with CDK4 and CDK6. Potent inhibitor.
Potential effector of TGF-beta induced cell cycle arrest.
-!- SUBUNIT: Heterodimer of CDKN2B with CDK4 or CDK6. Isoform 2 does
not interact with CDK4 nor CDK6.
-!- INTERACTION:
P11802:CDK4; NbExp=15; IntAct=EBI-711280, EBI-295644;
Q00534:CDK6; NbExp=10; IntAct=EBI-711280, EBI-295663;
P43364:MAGEA11; NbExp=3; IntAct=EBI-711280, EBI-739552;
Q9GZT8:NIF3L1; NbExp=3; IntAct=EBI-711280, EBI-740897;
Q9NZD8:SPG21; NbExp=4; IntAct=EBI-711280, EBI-742688;
Q13077:TRAF1; NbExp=5; IntAct=EBI-711280, EBI-359224;
-!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9230210}.
Note=Also found in the nucleus.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=2;
Name=1; Synonyms=p15;
IsoId=P42772-1; Sequence=Displayed;
Name=2; Synonyms=p10;
IsoId=P42772-2; Sequence=VSP_043898;
-!- TISSUE SPECIFICITY: Isoform 2 is expressed in normal
(keratinocytes, fibroblasts) and tumor cell lines.
{ECO:0000269|PubMed:9230210}.
-!- SIMILARITY: Belongs to the CDKN2 cyclin-dependent kinase inhibitor
family. {ECO:0000305}.
-!- WEB RESOURCE: Name=NIEHS-SNPs;
URL="http://egp.gs.washington.edu/data/cdkn2b/";
-!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
and Haematology;
URL="http://atlasgeneticsoncology.org/Genes/CDKN2BID187ch9p21.html";
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; U17075; AAC50075.1; -; mRNA.
EMBL; L36844; AAA50282.1; -; mRNA.
EMBL; AF004819; AAB69989.1; -; mRNA.
EMBL; CR536529; CAG38766.1; -; mRNA.
EMBL; AF513858; AAM44859.1; -; Genomic_DNA.
EMBL; AL449423; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; BC014469; AAH14469.1; -; mRNA.
EMBL; S69805; AAD14049.1; -; Genomic_DNA.
CCDS; CCDS6512.1; -. [P42772-1]
CCDS; CCDS6513.1; -. [P42772-2]
PIR; B55479; B55479.
RefSeq; NP_004927.2; NM_004936.3. [P42772-1]
RefSeq; NP_511042.1; NM_078487.2. [P42772-2]
UniGene; Hs.72901; -.
ProteinModelPortal; P42772; -.
SMR; P42772; -.
BioGrid; 107464; 16.
IntAct; P42772; 25.
MINT; P42772; -.
STRING; 9606.ENSP00000276925; -.
iPTMnet; P42772; -.
PhosphoSitePlus; P42772; -.
BioMuta; CDKN2B; -.
DMDM; 1168869; -.
MaxQB; P42772; -.
PaxDb; P42772; -.
PeptideAtlas; P42772; -.
PRIDE; P42772; -.
ProteomicsDB; 55555; -.
ProteomicsDB; 55556; -. [P42772-2]
DNASU; 1030; -.
Ensembl; ENST00000276925; ENSP00000276925; ENSG00000147883. [P42772-1]
Ensembl; ENST00000380142; ENSP00000369487; ENSG00000147883. [P42772-2]
GeneID; 1030; -.
KEGG; hsa:1030; -.
UCSC; uc003zpn.4; human. [P42772-1]
CTD; 1030; -.
DisGeNET; 1030; -.
EuPathDB; HostDB:ENSG00000147883.10; -.
GeneCards; CDKN2B; -.
HGNC; HGNC:1788; CDKN2B.
HPA; CAB000349; -.
HPA; HPA052838; -.
HPA; HPA063327; -.
MalaCards; CDKN2B; -.
MIM; 600431; gene.
neXtProt; NX_P42772; -.
OpenTargets; ENSG00000147883; -.
Orphanet; 618; Familial melanoma.
Orphanet; 652; Multiple endocrine neoplasia type 1.
PharmGKB; PA26321; -.
eggNOG; KOG0504; Eukaryota.
eggNOG; COG0666; LUCA.
GeneTree; ENSGT00390000004527; -.
HOGENOM; HOG000290191; -.
HOVERGEN; HBG050870; -.
InParanoid; P42772; -.
KO; K04685; -.
OMA; VNCYGRR; -.
OrthoDB; EOG091G0WSF; -.
PhylomeDB; P42772; -.
TreeFam; TF352389; -.
Reactome; R-HSA-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.
Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
Reactome; R-HSA-2559585; Oncogene Induced Senescence.
Reactome; R-HSA-69231; Cyclin D associated events in G1.
SIGNOR; P42772; -.
GeneWiki; CDKN2B; -.
GenomeRNAi; 1030; -.
PRO; PR:P42772; -.
Proteomes; UP000005640; Chromosome 9.
Bgee; ENSG00000147883; -.
CleanEx; HS_CDKN2B; -.
ExpressionAtlas; P42772; baseline and differential.
Genevisible; P42772; HS.
GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
GO; GO:0005829; C:cytosol; TAS:Reactome.
GO; GO:0005634; C:nucleus; IDA:UniProtKB.
GO; GO:0004861; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; IDA:BHF-UCL.
GO; GO:0019901; F:protein kinase binding; IPI:BHF-UCL.
GO; GO:0007050; P:cell cycle arrest; IMP:BHF-UCL.
GO; GO:0031668; P:cellular response to extracellular stimulus; IMP:BHF-UCL.
GO; GO:0031670; P:cellular response to nutrient; IMP:BHF-UCL.
GO; GO:0000086; P:G2/M transition of mitotic cell cycle; IMP:BHF-UCL.
GO; GO:0030219; P:megakaryocyte differentiation; IEP:UniProtKB.
GO; GO:0007093; P:mitotic cell cycle checkpoint; IMP:BHF-UCL.
GO; GO:0008285; P:negative regulation of cell proliferation; IMP:BHF-UCL.
GO; GO:0031658; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle; TAS:Reactome.
GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IMP:BHF-UCL.
GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl.
GO; GO:0042326; P:negative regulation of phosphorylation; IDA:BHF-UCL.
GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; TAS:Reactome.
GO; GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IMP:BHF-UCL.
GO; GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:BHF-UCL.
GO; GO:0048536; P:spleen development; IEA:Ensembl.
CDD; cd00204; ANK; 1.
Gene3D; 1.25.40.20; -; 1.
InterPro; IPR020683; Ankyrin_rpt-contain_dom.
InterPro; IPR036770; Ankyrin_rpt-contain_sf.
SUPFAM; SSF48403; SSF48403; 1.
PROSITE; PS50297; ANK_REP_REGION; 1.
1: Evidence at protein level;
Alternative splicing; ANK repeat; Cell cycle; Complete proteome;
Cytoplasm; Polymorphism; Reference proteome; Repeat; Tumor suppressor.
CHAIN 1 138 Cyclin-dependent kinase 4 inhibitor B.
/FTId=PRO_0000144184.
REPEAT 13 39 ANK 1; truncated.
REPEAT 46 74 ANK 2.
REPEAT 79 108 ANK 3.
REPEAT 112 138 ANK 4.
VAR_SEQ 54 138 MMMGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLD
TLVVLHRAGARLDVRDAWGRLPVDLAEERGHRDVAGYLRTA
TGD -> AGAPGPRRQGARERGARPRRIGAGT (in
isoform 2). {ECO:0000303|PubMed:9230210}.
/FTId=VSP_043898.
VARIANT 47 47 G -> E (in lung adenocarcinoma).
{ECO:0000269|PubMed:7882351}.
/FTId=VAR_001488.
VARIANT 50 50 A -> V (in lung adenocarcinoma).
{ECO:0000269|PubMed:7882351}.
/FTId=VAR_001489.
CONFLICT 20 22 SAA -> TP (in Ref. 2; AAA50282).
{ECO:0000305}.
CONFLICT 32 34 QLL -> HSW (in Ref. 2; AAA50282).
{ECO:0000305}.
SEQUENCE 138 AA; 14722 MW; 0D6FFBDFA6FEAD21 CRC64;
MREENKGMPS GGGSDEGLAS AAARGLVEKV RQLLEAGADP NGVNRFGRRA IQVMMMGSAR
VAELLLLHGA EPNCADPATL TRPVHDAARE GFLDTLVVLH RAGARLDVRD AWGRLPVDLA
EERGHRDVAG YLRTATGD


Related products :

Catalog number Product name Quantity
EIAAB06570 CDKN2B,Cyclin-dependent kinase 4 inhibitor B,Homo sapiens,Human,MTS2,MTS-2,Multiple tumor suppressor 2,p14-INK4b,p15INK4B,p15-INK4b
18-003-42901 Cyclin-dependent kinase 4 inhibitor B - p14-INK4b; p15-INK4b; Multiple tumor suppressor 2; MTS2 Polyclonal 0.05 mg Aff Pur
18-003-42901 Cyclin-dependent kinase 4 inhibitor B - p14-INK4b; p15-INK4b; Multiple tumor suppressor 2; MTS2 Polyclonal 0.1 mg Protein A
18-003-42900 Cyclin-dependent kinase 4 inhibitor B - p14-INK4b; p15-INK4b; Multiple tumor suppressor 2; MTS2 Polyclonal 0.05 mg Aff Pur
18-003-42900 Cyclin-dependent kinase 4 inhibitor B - p14-INK4b; p15-INK4b; Multiple tumor suppressor 2; MTS2 Polyclonal 0.1 mg Protein A
EIAAB06569 Cdkn2b,Cyclin-dependent kinase 4 inhibitor B,Mouse,Mus musculus,p14-INK4b,p15-INK4b
EIAAB06572 Cdkn2b,Cyclin-dependent kinase 4 inhibitor B,Ink4,p14-INK4b,p15-INK4b,Rat,Rattus norvegicus
15-288-21185 Cyclin-dependent kinase inhibitor 2A. isoforms 1_2_3 - Cyclin-dependent kinase 4 inhibitor A; CDK4I; p16-INK4; p16-INK4a; Multiple tumor suppressor 1; MTS1 Polyclonal 0.05 mg
15-288-21185 Cyclin-dependent kinase inhibitor 2A. isoforms 1_2_3 - Cyclin-dependent kinase 4 inhibitor A; CDK4I; p16-INK4; p16-INK4a; Multiple tumor suppressor 1; MTS1 Polyclonal 0.1 mg
E0794h ELISA kit CDK4I,CDKN2,CDKN2A,Cyclin-dependent kinase 4 inhibitor A,Cyclin-dependent kinase inhibitor 2A, isoforms 1_2_3,Homo sapiens,Human,MTS1,MTS-1,Multiple tumor suppressor 1,p16-INK4,p16INK4A,p16 96T
U0794h CLIA CDK4I,CDKN2,CDKN2A,Cyclin-dependent kinase 4 inhibitor A,Cyclin-dependent kinase inhibitor 2A, isoforms 1_2_3,Homo sapiens,Human,MTS1,MTS-1,Multiple tumor suppressor 1,p16-INK4,p16INK4A,p16-INK4a 96T
E0794h ELISA CDK4I,CDKN2,CDKN2A,Cyclin-dependent kinase 4 inhibitor A,Cyclin-dependent kinase inhibitor 2A, isoforms 1_2_3,Homo sapiens,Human,MTS1,MTS-1,Multiple tumor suppressor 1,p16-INK4,p16INK4A,p16-INK4 96T
EIAAB06571 Bos taurus,Bovine,CDKN2B,Cyclin-dependent kinase 4 inhibitor B,p14-INK4b
32-172 p16 (cyclin-dependent kinase inhibitor 2A, INK4a) is a tumor suppressor protein. It is a specific inhibitor of Cdk 4 _ Cdk 6, and a tumor suppressor involved in the pathogenesis of a variety of malign 0.1 mL
BMDV10102 p16INK4a (Cyclin Dependent Kinase Inhibitor), Tumor Suppressor Protein, 16kD, Clone ZJ11, Mab anti_Human, NO X w_Mouse or Rat; IF_Kinase_WB_IP (native & denatured) 0.5 ml.
BMDV10017 p16INK4a (Cyclin Dependent Kinase Inhibitor), Tumor Suppressor Protein, C_terminal, 16kD, co_precipitates cdk4 & cdk6, Rabbit anti_Human, NO X w_Mouse or Rat; paraffin, IH_Kinase_IP 0.5 ml.
BMDV10134 p15INK4b (Cyclin Dependent Kinase Inhibitor), 15kD, Clone DCS_114, Mab anti_Human, NO X w_Mouse or Rat; IF_IP (native) 0.5 ml.
EIAAB06559 CDI1,CDK2-associated dual-specificity phosphatase,CDKN3,CIP2,Cyclin-dependent kinase inhibitor 3,Cyclin-dependent kinase interactor 1,Cyclin-dependent kinase-interacting protein 2,Homo sapiens,Human,K
BMDV10001 p15INK4b (Cyclin Dependent Kinase Inhibitor), Mitotic Inhibitor_Suppressor Protein (MTS2), 15kD, Rabbit anti_Human, NO X w_Mouse or Rat; IF_IP 0.5 ml.
31-041 CDKN2B's gene lies adjacent to the tumor suppressor gene CDKN2A in a region that is frequently mutated and deleted in a wide variety of tumors. CDKN2B is a cyclin-dependent kinase inhibitor, which for 0.05 mg
E0794r ELISA CDK4I,Cdkn2a,Cyclin-dependent kinase 4 inhibitor A,Cyclin-dependent kinase inhibitor 2A, isoform 1,p16,p16-INK4,P16ink4a,p16-INK4a,Rat,Rattus norvegicus 96T
E0794m ELISA kit CDK4I,Cdkn2a,Cyclin-dependent kinase 4 inhibitor A,Cyclin-dependent kinase inhibitor 2A, isoforms 1_2,Mouse,Mus musculus,p16-INK4,P16ink4a,p16-INK4a 96T
E0794m ELISA CDK4I,Cdkn2a,Cyclin-dependent kinase 4 inhibitor A,Cyclin-dependent kinase inhibitor 2A, isoforms 1_2,Mouse,Mus musculus,p16-INK4,P16ink4a,p16-INK4a 96T
U0794r CLIA CDK4I,Cdkn2a,Cyclin-dependent kinase 4 inhibitor A,Cyclin-dependent kinase inhibitor 2A, isoform 1,p16,p16-INK4,P16ink4a,p16-INK4a,Rat,Rattus norvegicus 96T
E0794r ELISA kit CDK4I,Cdkn2a,Cyclin-dependent kinase 4 inhibitor A,Cyclin-dependent kinase inhibitor 2A, isoform 1,p16,p16-INK4,P16ink4a,p16-INK4a,Rat,Rattus norvegicus 96T


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur